VivoPower

VIVONASDAQUSD

THESIS ALERT

Email me when the VIVO thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$2.29
+$0.29 (+14.50%)Today 1M −26.13%
After hours$2.27−0.74%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$2.00
Prior regular-session close from the quote source.
$1.91–$2.34
Regular-session low and high so far today.
961.2K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$1.20–$6.86
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own VIVO if VivoPower is not yet an operating compounder; it is a high-risk recapitalization option whose value depends on funding, balance-sheet repair, and proving that customers will buy again at positive contribution margins.

VIVO price history

Latest price$2.29Today+$0.29 (+14.50%)
VIVO -20.49%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Capital access, not current operations, is the gating driver: VivoPower must secure outside funding, asset-sale proceeds, or creditor relief before any commercial plan can create durable equity value.StrengtheningMateriality: High

    IFRS FY2025 year-end cash was $60,000. If funding arrives on tolerable terms, shareholders retain option value; if it does not, creditors or new capital can capture the upside before operations recover.

    Watch: A binding refinancing, equity raise, or strategic investment closes with enough unrestricted cash to fund multiple reporting periods.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    IFRS FY2025 year-end cash was $60,000.

    Open source ↗
  • The business cannot be valued as a growth platform until customer demand reappears in repeatable commercial volume rather than isolated activity from a near-zero base.StrengtheningMateriality: High

    IFRS annual revenue fell from $10.160 million in FY2022 to $4.055 million in FY2023, then to $16,000 in FY2024. A real order book would make the company financeable and give operating leverage a chance; absent that, new capital only funds burn.

    Watch: VivoPower announces named customer contracts with delivery schedules and economics that imply recurring revenue rather than one-off sales.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    IFRS annual revenue fell from $10.160 million in FY2022 to $4.055 million in FY2023, then to $16,000 in FY2024.

    Open source ↗
  • VivoPower must prove that new work can be priced above procurement, delivery, and service costs; otherwise revenue growth would be subsidized and value-destructive.HoldingMateriality: Medium

    IFRS FY2025 annual gross_profit was positive $11,000 on $61,000 of revenue. Positive unit economics would allow scale to matter; negative gross profit would mean every new dollar of sales consumes more capital.

    Watch: New contracts require below-cost pricing to win work from incumbent providers.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    IFRS FY2025 annual gross_profit was positive $11,000 on $61,000 of revenue.

    Open source ↗
  • The operating platform is not right-sized for the present revenue base, so management must either rebuild scale quickly or remove fixed costs before gross-profit wins can reach shareholders.StrengtheningMateriality: Medium

    IFRS FY2025 annual operating_income was negative $8.723 million on $61,000 of revenue. If overhead remains disconnected from revenue, even better gross margins will not stop cash burn; if fixed costs reset, smaller revenue can create a path to break-even.

    Watch: Management completes disclosed overhead reductions, divestitures, or outsourcing that structurally lower the cash cost base.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    IFRS FY2025 annual operating_income was negative $8.723 million on $61,000 of revenue.

    Open source ↗
  • Balance-sheet repair is a prerequisite to per-share value creation because liabilities can dictate strategic choices and absorb turnaround value before common equity benefits.StrengtheningMateriality: Medium

    IFRS FY2025 year-end liabilities were $77.024 million. A creditor-friendly restructuring can leave the business alive but existing shareholders diluted or impaired; a clean liability settlement preserves the option on recovery.

    Watch: Major liabilities are converted, extended, or settled without punitive dilution to common shareholders.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    IFRS FY2025 year-end liabilities were $77.024 million.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Capital access, not current operations, is the gating driver: VivoPower must secure outside funding, asset-sale proceeds, or creditor relief before any commercial plan can create durable equity value. If funding arrives on tolerable terms, shareholders retain option value; if it does not, creditors or new capital can capture the upside before operations recover.

The business cannot be valued as a growth platform until customer demand reappears in repeatable commercial volume rather than isolated activity from a near-zero base. A real order book would make the company financeable and give operating leverage a chance; absent that, new capital only funds burn.

VivoPower must prove that new work can be priced above procurement, delivery, and service costs; otherwise revenue growth would be subsidized and value-destructive. Positive unit economics would allow scale to matter; negative gross profit would mean every new dollar of sales consumes more capital.

The operating platform is not right-sized for the present revenue base, so management must either rebuild scale quickly or remove fixed costs before gross-profit wins can reach shareholders. If overhead remains disconnected from revenue, even better gross margins will not stop cash burn; if fixed costs reset, smaller revenue can create a path to break-even.

Balance-sheet repair is a prerequisite to per-share value creation because liabilities can dictate strategic choices and absorb turnaround value before common equity benefits. A creditor-friendly restructuring can leave the business alive but existing shareholders diluted or impaired; a clean liability settlement preserves the option on recovery.

All standing thesis claims
Original report summary

VivoPower is not yet an operating compounder; it is a high-risk recapitalization option whose value depends on funding, balance-sheet repair, and proving that customers will buy again at positive contribution margins.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for VivoPower

Where the evidence on VivoPower stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.

Bull case: what the evidence supports

  • Capital access, not current operations, is the gating driver: VivoPower must secure outside funding, asset-sale proceeds, or creditor relief before any commercial plan can create durable equity value.

    sec.gov ↗

  • The business cannot be valued as a growth platform until customer demand reappears in repeatable commercial volume rather than isolated activity from a near-zero base.

    sec.gov ↗

  • VivoPower must prove that new work can be priced above procurement, delivery, and service costs; otherwise revenue growth would be subsidized and value-destructive.

    sec.gov ↗

  • The operating platform is not right-sized for the present revenue base, so management must either rebuild scale quickly or remove fixed costs before gross-profit wins can reach shareholders.

    sec.gov ↗

  • Balance-sheet repair is a prerequisite to per-share value creation because liabilities can dictate strategic choices and absorb turnaround value before common equity benefits.

    sec.gov ↗

Bear case: what would count against it

  • A binding refinancing, equity raise, or strategic investment closes with enough unrestricted cash to fund multiple reporting periods.

    sec.gov ↗

  • VivoPower announces named customer contracts with delivery schedules and economics that imply recurring revenue rather than one-off sales.

    sec.gov ↗

  • New contracts require below-cost pricing to win work from incumbent providers.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · VivoPower

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed VivoPower’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Foreign issuer material report (6-K).

    VivoPower filed an SEC report on 2026-08-28: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

  2. Mixed
    Foreign issuer material report (6-K).

    VivoPower filed an SEC report on 2026-08-21: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

  3. Mixed
    Foreign issuer material report (6-K).

    VivoPower filed an SEC report on 2026-08-03: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A binding refinancing, equity raise, or strategic investment closes with enough unrestricted cash to fund multiple reporting periods.
  • VivoPower announces named customer contracts with delivery schedules and economics that imply recurring revenue rather than one-off sales.
  • New contracts require below-cost pricing to win work from incumbent providers.
  • Management completes disclosed overhead reductions, divestitures, or outsourcing that structurally lower the cash cost base.
  • Major liabilities are converted, extended, or settled without punitive dilution to common shareholders.

VIVO news

Loading headlines…

Financial statements

VIVO income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

VIVO: quick answers

What is VIVO's short interest?
As of October 30, 2026, 2.0M VIVO shares were sold short, down 4.6% from the count before. At the stock's average daily volume that is 1.5 days to cover. FINRA publishes the count twice a month. VIVO short interest history
Have members of Congress traded VIVO?
5 trades in VIVO have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed VIVO trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.